Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full 'TULSA Days'
Profound Medical Launches 'Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th - Conference Call to Follow
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Profound Medical to Release First Quarter 2026 Financial Results on May 7 - Conference Call to Follow
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
